get a key
steadybase-$ company WINT
account_id none on file
legal_name Windtree Therapeutics Inc /de/
ticker WINT
cik 946486
domain windtreetx.com
entry_point_account_id none on file
name Windtree Therapeutics Inc.
exchange OTC
sector Health Care
hq Warrington, PA, United States
calls 0 filings 1 executives 8 family 0
why_nownone on file
callsnone on file
filings
Since completing our Phase 2 study of lucinactant ( KL4 surfactant) for patients with severe COVID- 19 associated ARDS and lung injury in January 2022, in order to preserve resources for the highest priority programs, we have begun to reduce costs not already being performed by our licensee, Lee’s (HK) and Zhaoke, under the terms of our Original License Agreement.

filing / Nov 19, 2025 / receipt

executives
Daniel Geffken director - receipt
James Huang Chairman - receipt
Jamie McAndrew Vice President and Chief Accounting Officer linkedin receipt
Jed Latkin President and Chief Executive Officer - receipt
John A. Tattory Senior Vice President and Chief Financial Officer - receipt
John G. Cooper President and Chief Financial Officer - receipt
Leanne Kelly director - receipt
W. Thomas Amick Chief Executive Officer - receipt
familynone on file
upcomingnone on file
changes
2026-01-07 President and Chief Operating Officer, departed sec_8k
2025-06-27 Senior Vice President, departed sec_8k
2025-01-13 director, appointed sec_8k
2024-11-15 Senior Vice President, appointed sec_8k
2024-11-14 President and Chief Executive Officer, appointed sec_8k
2024-11-14 President and Chief Executive Officer, retiring sec_8k
2024-10-01 Senior Vice President and Chief Financial Officer, appointed sec_8k
2023-08-28 Vice President, appointed sec_8k
2023-01-19 Interim Chief Financial Officer, appointed sec_8k
2019-04-30 director, appointed sec_8k
2018-12-21 Chairman, appointed sec_8k
2016-02-03 President and Chief Executive Officer, appointed sec_8k
mcp_package_hint
steadybase-$